Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus

This study identifies the E3 ubiquitin ligase ITCH as a critical host factor that promotes SARS-CoV-2 replication and virion release by enhancing viral protein ubiquitination and assembly, facilitating autophagosome-dependent secretion, and suppressing protease-mediated spike protein destabilization, thereby highlighting ITCH as a promising therapeutic target.

The Gist

The Big Picture: A Viral Factory and Its "Foreman"

Imagine the SARS-CoV-2 virus as a tiny, sophisticated factory trying to build and ship out millions of copies of itself to infect your body. To do this, it needs to assemble specific parts (its structural proteins) and get them out the door without breaking.

This study discovered a specific human protein called ITCH that acts like a hyper-active foreman inside the cell. Instead of stopping the virus, the virus actually tricks the cell into turning ITCH "on." Once activated, ITCH helps the virus build better factories and ship out more products. If you fire this foreman (by blocking ITCH), the virus factory grinds to a halt.

Here is how ITCH helps the virus in three main ways:

---

1. The "Velcro" Effect: Assembling the Virus

The Science: The virus has four main building blocks: Spike (S), Envelope (E), and Membrane (M) proteins. They need to stick together to form a complete virus particle.
The Analogy: Imagine trying to build a Lego castle, but the pieces are slippery and keep sliding apart.

• What ITCH does: ITCH acts like a super-strong glue (specifically, it adds "glue tags" called ubiquitin). It sticks these viral Lego pieces together tightly.
• The Result: Because ITCH glues the pieces together, the virus can assemble its structure much faster and more securely. Without ITCH, the virus parts fall apart before they can form a complete particle.

2. The "Secret Tunnel": Getting the Virus Out

The Science: Once the virus is built, it needs to leave the cell to infect others. Usually, cells send waste to a "trash compactor" (the lysosome) to be destroyed.
The Analogy: Imagine the virus is a package that needs to be mailed, but the cell's security system wants to throw it in the trash.

• What ITCH does: ITCH tags the viral packages and tricks the cell's delivery system. Instead of sending the packages to the trash, ITCH routes them through a secret tunnel (the autophagosome) that leads directly to the outside of the cell.
• The Result: The virus escapes the cell safely and efficiently, avoiding the "trash compactor." If you remove ITCH, the virus packages get stuck inside or get thrown in the trash, and no new infections happen.

3. The "Bodyguard": Protecting the Virus's Key

The Science: The virus has a "key" called the Spike protein (S) that it uses to unlock cells. This key is very fragile and can be cut or broken by the cell's own enzymes (like Furin and Cathepsin L).
The Analogy: Imagine the virus's key is made of glass. If it gets cracked, it won't work. The cell has "scissors" (enzymes) that try to cut the key.

• What ITCH does: ITCH acts as a bodyguard. It messes with the cell's scissors, hiding them away or stopping them from sharpening. It keeps the scissors in the wrong room so they can't reach the key.
• The Result: The Spike protein stays whole and strong. A strong key means the virus can successfully unlock and infect new cells. Without ITCH, the scissors cut the key, and the virus becomes useless.

---

The Twist: The Virus Hijacks the Foreman

The most surprising part of the study is that the virus doesn't just use ITCH; it activates it.

• When the virus enters a cell, it triggers a signal (via a protein called JNK1) that wakes up ITCH.
• Once ITCH is awake, it goes to work helping the virus.
• The study found that if you block ITCH (using a drug called Clomipramine or by genetically removing it), the virus production drops by hundreds or even thousands of times.

Why This Matters

This research gives us a new target for fighting COVID-19.

• Current treatments often try to stop the virus directly.
• This new idea suggests we could treat the host (us). If we can temporarily "fire" the ITCH foreman in our cells, we can stop the virus from building and escaping, effectively starving the infection.

In short: The SARS-CoV-2 virus is a clever thief that recruits a human security guard (ITCH) to help it break into the house, build a getaway car, and escape. If we can convince that guard to quit, the thief gets stuck inside.

Technical Summary

1. Problem Statement

Despite vaccination efforts, SARS-CoV-2 continues to pose a significant public health threat, causing acute infections and long-term sequelae (Long COVID). While the viral structure is well-characterized, the specific host cellular mechanisms that regulate the viral life cycle—particularly virion assembly, egress, and the post-translational processing of structural proteins—remain incompletely understood. Identifying host factors that are hijacked by the virus for its replication is crucial for developing novel antiviral therapeutics. Specifically, the role of E3 ubiquitin ligases in modulating SARS-CoV-2 structural proteins (Spike, Envelope, Membrane) and their interactions with host proteases requires further elucidation.

2. Methodology

The study employed a multi-faceted approach combining proteomics, molecular biology, cell biology, and virology:

• Proteomic Screening: Co-immunoprecipitation (Co-IP) followed by Mass Spectrometry (LC-MS/MS) was performed on SARS-CoV-2 structural proteins (S, E, M) expressed in HEK293 cells to identify interacting host E3 ligases.
• Cell Models:
  • HEK293 cells: Used for transient transfection and protein interaction studies.
  • Vero-E6-TMPRSS2 (vT2) cells: Used for SARS-CoV-2 infection, viral replication assays, and CRISPR/Cas9-mediated knockout of ITCH.
  • Calu-3-ACE2 cells: Human lung epithelial cells used to validate findings in a human-relevant model.
• Genetic Manipulation: Generation of ITCH knockout (KO) and p62 knockdown cell lines using CRISPR/Cas9 and shRNA, respectively. Expression of wild-type (WT) ITCH and catalytically inactive mutants (ITCH-CS, C830S) was utilized to distinguish ligase-dependent effects.
• Biochemical Assays:
  • Immunoprecipitation (IP) & Western Blotting: To assess protein-protein interactions, ubiquitination status (K48 vs. K63 linkages), and protein stability.
  • Denaturing IP: Specifically used to analyze ubiquitinated viral proteins.
  • Proteasome/Proteasome Inhibition: Treatment with MG132 and Cycloheximide (CHX) to determine degradation pathways.
• Cellular Imaging: Immunofluorescence (IF) and Proximity Ligation Assays (PLA) were used to visualize subcellular localization, colocalization (e.g., with p62, LC3B, LAMP1, Furin, CTSL), and protein interactions in situ.
• Virological Assays:
  • TCID₅₀: To measure infectious viral titers.
  • qRT-PCR: To quantify viral RNA copy numbers.
  • Cytopathic Effect (CPE) Assays: To assess cell viability post-infection.
• Pharmacological Inhibition: Use of Clomipramine (Clom), a known HECT E3 ligase inhibitor, to test antiviral efficacy.
• Bioinformatics: Analysis of single-nucleus RNA sequencing (snRNA-seq) data from COVID-19 patient lungs to assess ITCH expression patterns.

3. Key Contributions & Results

A. ITCH Ubiquitinates and Interacts with Envelope (E) and Membrane (M) Proteins

• Identification: ITCH was identified as the E3 ligase with the highest peptide count interacting with SARS-CoV-2 structural proteins.
• Mechanism: ITCH promotes K63-linked polyubiquitination of the E and M proteins. This does not require the formation of complete virus-like particles (VLPs) but occurs independently.
• Interaction Enhancement: ITCH-mediated ubiquitination enhances the physical interaction between:
  • E and S proteins.
  • M and E proteins.
  • This facilitates the assembly of structural protein complexes necessary for virion formation.

B. ITCH Promotes Autophagosome-Dependent Secretion of E and M

• Secretion Pathway: ITCH facilitates the secretion of E and M proteins from the cell.
• Role of p62: ITCH-mediated ubiquitination of E and M creates binding sites for the autophagy receptor p62.
• Trafficking: The p62-E/M complexes are recruited to autophagosomes (marked by LC3B). Crucially, these complexes are not targeted to lysosomes for degradation (no colocalization with LAMP1). Instead, they utilize the autophagosome pathway for secretion (exocytosis), aiding in virion egress.
• Validation: Depletion of p62 or ITCH significantly reduces the extracellular levels of E and M proteins while increasing their intracellular accumulation.

C. ITCH Stabilizes the Spike (S) Protein by Inhibiting Proteolytic Cleavage

Unlike E and M, ITCH does not ubiquitinate the Spike (S) protein. Instead, it regulates S stability by modulating host proteases:

• Furin Disruption: ITCH expression disrupts the localization of Furin (a proprotein convertase) from the trans-Golgi network (TGN) to a dispersed cytoplasmic pattern. This reduces the cleavage of S at the S1/S2 polybasic cleavage site (PPC site) within the TGN.
• CTSL Inhibition: ITCH inhibits the maturation of Cathepsin L (CTSL). It increases the levels of the pro-enzyme form of CTSL and decreases the mature double-chain form.
• Outcome: By reducing the activity of Furin and CTSL, ITCH prevents excessive intracellular cleavage and degradation of the S protein. This preserves the integrity of the full-length S protein, which is essential for the formation of infectious virions. (Note: While some cleavage is necessary for entry, excessive intracellular cleavage destabilizes the virion).

D. ITCH is Activated During SARS-CoV-2 Infection

• Activation Mechanism: SARS-CoV-2 infection induces the phosphorylation of JNK1, which in turn phosphorylates ITCH at T222, significantly enhancing its E3 ligase activity.
• Temporal Dynamics: ITCH activation is low during early infection but robustly increases during the viral replication stage (48 hours post-infection).
• Expression: ITCH is ubiquitously expressed in human lung cells and is upregulated in specific cell types (B cells, fibroblasts, epithelial, and endothelial cells) during natural infection.

E. Inhibition of ITCH Suppresses Viral Replication

• Genetic Knockout: ITCH KO in vT2 cells reduced viral copy numbers by ~8-fold and infectious titers (TCID₅₀) by >25-fold.
• Pharmacological Inhibition: Treatment with Clomipramine (Clom) significantly reduced viral replication and protected cells from cytopathic effects. While Clom inhibits multiple HECT ligases, the partial rescue of the phenotype in ITCH KO cells suggests that ITCH is a primary, though not sole, target.
• Human Cell Validation: Depletion of ITCH in human Calu-3 lung cells also resulted in a significant decrease in viral replication, confirming the relevance of this pathway in human physiology.

4. Significance

• Novel Mechanism of Virion Egress: The study reveals a previously uncharacterized mechanism where SARS-CoV-2 utilizes the host autophagy receptor p62 and autophagosomes for the secretion (rather than degradation) of structural proteins, driven by ITCH-mediated K63 ubiquitination.
• Dual Regulation of Structural Proteins: It demonstrates that a single host factor (ITCH) regulates the viral life cycle through two distinct mechanisms:
  1. Ubiquitination-dependent: Promoting assembly and secretion of E/M.
  2. Ubiquitination-independent: Stabilizing S by altering the trafficking and maturation of host proteases (Furin and CTSL).
• Therapeutic Target: ITCH is identified as a critical host dependency factor. Its inhibition significantly impairs viral proliferation without necessarily requiring direct viral targeting, offering a potential strategy for broad-spectrum antiviral therapy.
• Neurodegenerative Link: The authors note that ITCH is also implicated in neurodegenerative diseases (Alzheimer's, ALS) via Golgi and lysosomal trafficking. The findings suggest a potential mechanistic link between SARS-CoV-2 infection and neurodegenerative pathology, as the virus hijacks the same trafficking pathways.

In conclusion, the paper establishes ITCH as a central host regulator that SARS-CoV-2 hijacks to optimize virion assembly, protect the Spike protein from premature degradation, and facilitate viral egress, making it a promising target for antiviral drug development.